Written Exposure Therapy for Nurses
Open Pilot of Written Exposure Therapy for Nurses Experiencing Work-Related Posttraumatic Stress
1 other identifier
interventional
10
1 country
1
Brief Summary
Nurses often experience elevated levels of stress, overwork, and trauma in the workplace, leading to posttraumatic stress disorder (PTSD), depression, burnout, and even nurse turnover. While effective therapies for PTSD exist, barriers to treatment arise from nursing culture, such as workplace stigma about mental health problems, fear that psychological status may impact performance evaluations, and demands of shiftwork. There is a pressing need for scalable evidence-based interventions tailored to nursing culture to effectively address PTSD and related mental health issues. The study aimed to assess the feasibility, safety, and acceptability of a tailored evidence-based treatment, Written Exposure Therapy (WET), for nurses experiencing work-related traumatic stress. This single-arm open pilot study with pre- and post-intervention assessments, included participants from two nursing schools' alumni. Eligibility criteria included nurses screening positive for work-related trauma with a report of at least two PTSD symptoms. Participants engaged in a self-administered, asynchronous, five-week online writing session, facilitated by WET-trained nurses. Outcomes measures (PTSD, depression, anxiety, burnout, and intention to quit) were assessed at baseline, post-intervention, and 5-weeks follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 21, 2024
CompletedFirst Posted
Study publicly available on registry
May 29, 2024
CompletedMay 29, 2024
May 1, 2024
1.1 years
May 21, 2024
May 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Posttraumatic stress disorder
The PTSD Checklist for DSM-5 was used to assess symptoms of posttraumatic stress disorder in the past month. The total score ranges from 0-80, with higher scores indicating more severe PTSD symptoms.
Baseline, immediately post-intervention, and 5 weeks follow-up
Secondary Outcomes (4)
Depression
Baseline, immediately post-intervention, and 5 weeks follow-up
Anxiety
Baseline, immediately post-intervention, and 5 weeks follow-up
Professional Quality of Life
Baseline, immediately post-intervention, and 5 weeks follow-up
Intention to Quit
Baseline, immediately post-intervention, and 5 weeks follow-up
Study Arms (1)
Written Exposure Therapy
EXPERIMENTALWET is a trauma-focused therapy for PTSD. It includes five writing sessions.
Interventions
The five weekly WET sessions were delivered online via Canvas. Five session modules were created, each containing writing instructions for the respective session and an assignment feature for participants to upload their narratives. All sessions included 30 minutes of writing. Following instructions, participants wrote about a specific work-related trauma event in detail and described the emotions and thoughts experienced during the event. While all sessions were self-paced, participants were advised to complete each subsequent session within one week. Participants had the option to self-administer sessions or participate in Zoom "office hours" for live writing sessions with a facilitator who had completed WET training providing the writing instructions.
Eligibility Criteria
You may qualify if:
- Work-related trauma
- Posttraumatic stress disorder
You may not qualify if:
- Current substance abuse
- Current suicidality
- Current psychiatric treatment with psychotherapy or psychotropic medications other than selective serotonin (and norepinephrine) reuptake inhibitors (SSRI/SNRI).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Texas at Austinlead
- University of Michigancollaborator
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 21, 2024
First Posted
May 29, 2024
Study Start
February 1, 2022
Primary Completion
March 1, 2023
Study Completion
September 1, 2023
Last Updated
May 29, 2024
Record last verified: 2024-05